Table 2.
Number of Study Participants Eligible for any Process Measure (for Overall Performance) and Each Individual Measure, and Proportion Who Received Recommended Care or Achieved Outcomes Benchmarks Among Participants with Low Clinical Complexity
(Below the Median Value of Clinical Complexity) vs. High Complexity (Above the Median)
| Low clinical complexity | High clinical complexity | -value* | ||
|---|---|---|---|---|
| Process measures | ||||
| Overall process performance higher than expected | 35,927 | 53.1% | 56.1% | <.001 |
| Mammography | 2,917 | 86.6% | 84.1% | 0.06 |
| Colon cancer screening | 30,865 | 72.4% | 72.7% | 0.6 |
| Influenza vaccination | 20,137 | 71.5% | 77.5% | <.001 |
| Pneumococcal vaccination | 29,619 | 85.7% | 88.6% | <.001 |
| Lipids checked | 33,573 | 93.5% | 95.5% | <.001 |
| ACE-I in heart failure | 3,103 | 86.5% | 88.2% | 0.2 |
| Diabetic eye examination | 10,627 | 76.2% | 80.4% | <.001 |
*P-values based on chi-square test